Antiphospholipid Syndrome in Systemic Autoimmune Diseases, Second Edition provides an overview of our current understanding of this major disease. It includes the latest information on the new pathogenetic mechanisms involved, along with clinical manifestations in both the thrombotic and non-thrombotic manifestations of this important disease. Antiphospholipid syndrome is an autoimmune disease that causes abnormal blood clots. It is now recognized as a major cause of common conditions, including stroke, heart attack, miscarriage, epilepsy, and memory loss, and as such is gaining recognition in all branches of medicine, from obstetrics to cardiology, and from psychiatry to orthopedics.
Chapter 1. History, Classification, and Subsets of the Antiphospholipid Syndrome Chapter 2. Epidemiology of the Antiphospholipid Syndrome Chapter 3. Mechanisms of Action of the Antiphospholipid Antibodies Chapter 4. Laboratory Markers With Clinical Significance in the Antiphospholipid Syndrome Chapter 5. Genetic and Epigenetic Aspects of Antiphospholipid Syndrome: What we knew, what we know Chapter 6. Thrombotic Manifestations of the Antiphospholipid Syndrome Chapter 7. Obstetric Manifestations of the Antiphospholipid Syndrome Chapter 8. Thrombocytopenia in the Antiphospholipid Syndrome Chapter 9. Nonclassification Criteria Manifestations of the Antiphospholipid Syndrome Chapter 10. Paediatric Antiphospholipid Syndrome Chapter 11. Antiphospholipid Antibodies and Their Relationship With Infections, Vaccines, and Drugs Chapter 12. Antiphospholipid Syndrome Associated With Malignancies Chapter 13. Antiphospholipid Antibodies and Atherosclerosis Chapter 14. Global Antiphospholipid Syndrome Score Chapter 15. Primary Prophylaxis in Patients With Positive Antiphospholipid Antibodies Chapter 16. Treatment of Thrombosis in Antiphospholipid Syndrome Chapter 17. Treatment of Catastrophic Antiphospholipid Syndrome Chapter 18. Treatment of Pregnancy Complications in Antiphospholipid Syndrome Chapter 19. Prognosis in Antiphospholipid Syndrome